Citizens reiterates Skyward Specialty stock rating on diversified book

Citizens reiterated a Market Outperform rating and $80 price target for Skyward Specialty (SKWD), citing its diversification and undervaluation. The company reported Q2 2026 earnings of $1.30 per share, beating estimates, with revenue of $489.53 million. Piper Sandler maintained an Overweight rating with a $72 target. Citizens noted sector-wide negative book value impacts due to market conditions.

Original reporting
Published Oct 12, 2026, 9:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 10:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SKWD
Bullish
medium confidence
Mentioned
$SKWD
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SKWDBullishLow
01

Why it matters

Analyst reiteration adds modest bullish bias but does not introduce new material information.

02

Market read

Provides a slight positive nudge for SKWD but limited trading relevance.

03

What to watch

Potential headwinds from broader P&C cycle and interest‑rate dynamics could limit upside.

Relevance 4/10Novelty 3/10Timing: today

Background

The article recaps recent Q2 earnings beat and provides an analyst rating update.

Company-level read

Ticker impact

$SKWDBullishMedium confidence
Context

Citizens reiterated a Market Outperform rating and raised the price target to $80 for Skyward Specialty Insurance Group.

Expected impact

likely upward pressure as the rating and higher target are priced in

Evidence & confidence

The reiteration of a bullish rating and a higher price target can attract buying interest, especially after the recent earnings beat.

Market effects

May boost sentiment in the specialty insurance sector as investors see a stable earnings outlook.

Limited to U.S. insurers; no broader regional effect.

Minimal global impact.

Counterpoint

The rating reiteration may be premature if the soft P&C market worsens.

Key entities

  • Citizens

    Equity research firm providing the rating and price target.

Related articles

$SKWDHighAI 8/10

Raymond James reiterates Strong Buy on Skyward Specialty stock

Raymond James reiterated a Strong Buy rating and $75.00 price target for Skyward Specialty Insurance Group (NASDAQ:SKWD), citing strong value and growth prospects. The stock has risen 39% in six months. Q3 2026 net investment income increased 54% YoY to $34 million. Management prioritizes debt repayment over share buybacks. Raymond James raised its 2026 EPS estimate to $5.10. Skyward reported Q3 EPS of $1.28, beating estimates by 42.2%, with revenue at $501.77 million.

$SKWDMed

Jefferies raises Skyward Specialty Insurance stock price target to $64

Jefferies increased its price target for Skyward Specialty Insurance (NASDAQ:SKWD) to $64, maintaining a Hold rating. The firm cited the company's diversification and attractive valuation, but noted rising competition. Skyward reported Q3 2026 earnings of $1.28 per share, exceeding estimates, with revenue of $501.77 million. The stock declined due to competitive pressures and lack of 2027 guidance.

$SKWDHighAI 8/10

Skyward (SKWD) Q3 2026 Earnings Call Transcript

Skyward (SKWD) reported Q3 2026 earnings with operating income of $58M ($1.28 per diluted share) and 9M operating income of $175M. Gross written premiums rose 9% to $803M, with fee-generating premiums up 18% to $517M. Combined ratio was 89.9%, and operating return on equity exceeded 20%. Skyward Specialty saw 10% premium growth, while Apollo's premiums increased 3%, with fee income up 18%.

$SKWDMed

Skyward Specialty Insurance Group Q3 Earnings Call Highlights

Skyward Specialty Insurance Group reported a 13% rise in net earned premiums for the first nine months, with Q3 combined ratio at 88.3. Lower dairy and livestock coverage uptake and treaty year adjustments affected growth. Apollo's gross written premiums increased 3%, with fee-generating premiums up 18%. The company launched new initiatives and expects to provide 2027 guidance in Q4. Book value per share rose 15% to $28.74, with net investment income up 54%.

$SKWDMed

Skyward: Q3 Earnings Snapshot

Skyward Specialty Insurance Group (SKWD) reported Q3 profit of $49.8M, or $1.09 per share, beating analyst estimates of $1.22 per share. Adjusted earnings were $1.28 per share. Revenue was $455.3M, missing expectations of $507.3M.